Drug Topics September 25, 2023
Rose McNulty

A new study found that participants reported improved glycemic control and improved quality of life with smartwatch-integrated, do-it-yourself continuous glucose monitoring.

A small study of patients with type 1 diabetes (T1D) found that smartwatch-integrated, do-it-yourself continuous glucose monitoring (DIY-CGM) improved the experience of diabetes self-management compared with intermittently scanned CGM (isCGM).

The qualitative study was published in the journal Diabetic Medicine and suggests that DIY-CGM, a less costly alternative to standard real-time continuous glucose monitoring (rt-CGM), may reduce disease burden compared with isCGM.1 Patients reported that DIY-CGM made accessing glucose information easier and that DIY-CGM reduced self-management burden vs isCGM.

While rt-CGM is recommended in major guidelines for T1D management, the global uptake of rt-CGM has been slow due to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Survey / Study, Technology, Trends, Wearables
Seniors deserve timely access to care, not bureaucratic hurdles | Viewpoint
From Noise To Clarity, Here’s An Empowering Way To Hearing Health
More than half of US adults could benefit from GLP-1 medications, researchers find
Data show 24.3% of U.S. adults had chronic pain in past three months in 2023
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article